BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sherr JL, Tauschmann M, Battelino T, de Bock M, Forlenza G, Roman R, Hood KK, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies. Pediatr Diabetes 2018;19 Suppl 27:302-25. [PMID: 30039513 DOI: 10.1111/pedi.12731] [Cited by in Crossref: 94] [Cited by in F6Publishing: 62] [Article Influence: 31.3] [Reference Citation Analysis]
Number Citing Articles
1 Walker AF, Hood KK, Gurka MJ, Filipp SL, Anez-Zabala C, Cuttriss N, Haller MJ, Roque X, Naranjo D, Aulisio G, Addala A, Konopack J, Westen S, Yabut K, Mercado E, Look S, Fitzgerald B, Maizel J, Maahs DM. Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 Diabetes. Diabetes Care 2021:dc202753. [PMID: 34001535 DOI: 10.2337/dc20-2753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Addala A, Auzanneau M, Miller K, Maier W, Foster N, Kapellen T, Walker A, Rosenbauer J, Maahs DM, Holl RW. A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison. Diabetes Care 2021;44:133-40. [PMID: 32938745 DOI: 10.2337/dc20-0257] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
3 Mulvaney SA, Vaala SE, Carroll RB, Williams LK, Lybarger CK, Schmidt DC, Dietrich MS, Laffel LM, Hood KK. A mobile app identifies momentary psychosocial and contextual factors related to mealtime self-management in adolescents with type 1 diabetes. J Am Med Inform Assoc 2019;26:1627-31. [PMID: 31529065 DOI: 10.1093/jamia/ocz147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
4 Massa GG, Gys I, Bevilacqua E, Wijnands A, Zeevaert R. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 2019;152:111-8. [PMID: 31121275 DOI: 10.1016/j.diabres.2019.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Lee YJ, Lee YA, Kim JH, Chung HR, Gu MJ, Kim JY, Shin CH. The durability and effectiveness of sensor-augmented insulin pump therapy in pediatric and young adult patients with type 1 diabetes. Ann Pediatr Endocrinol Metab 2020;25:248-55. [PMID: 33401881 DOI: 10.6065/apem.2040048.024] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Hennessy LD, De Lange M, Wiltshire EJ, Jefferies C, Wheeler BJ. Youth and non‐European ethnicity are associated with increased loss of publicly funded insulin pump access in New Zealand people with type 1 diabetes. Diabet Med 2021;38. [DOI: 10.1111/dme.14450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Crossen S, Xing G, Hoch JS. Changing costs of type 1 diabetes care among US children and adolescents. Pediatr Diabetes 2020;21:644-8. [PMID: 32061049 DOI: 10.1111/pedi.12996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lipman TH, Willi SM, Lai C, Smith JA, Patil O, Hawkes CP. Insulin Pump Use in Children with Type 1 Diabetes: Over a Decade of Disparities. Journal of Pediatric Nursing 2020;55:110-5. [DOI: 10.1016/j.pedn.2020.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
9 Thivolet C, Gaudilliere M, Villar Fimbel S, Bendelac N, Mestre B, Protsenko N, Brunot S, Nicolino M. Hybrid closed Loop improved glucose control compared to sensor-augmented pumps in outpatients with type 1 diabetes in real-life conditions with telehealth monitoring. Acta Diabetol 2021. [PMID: 34725723 DOI: 10.1007/s00592-021-01820-9] [Reference Citation Analysis]
10 Marigliano M, Eckert AJ, Guness PK, Herbst A, Smart CE, Witsch M, Maffeis C; SWEET Study Group. Association of the use of diabetes technology with HbA1c and BMI-SDS in an international cohort of children and adolescents with type 1 diabetes: The SWEET project experience. Pediatr Diabetes 2021. [PMID: 34716736 DOI: 10.1111/pedi.13274] [Reference Citation Analysis]
11 Rodríguez-rodríguez I, Rodríguez J, Woo WL, Wei B, Pardo-quiles D. A Comparison of Feature Selection and Forecasting Machine Learning Algorithms for Predicting Glycaemia in Type 1 Diabetes Mellitus. Applied Sciences 2021;11:1742. [DOI: 10.3390/app11041742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
12 Asarani NAM, Reynolds AN, Boucher SE, de Bock M, Wheeler BJ. Cutaneous Complications With Continuous or Flash Glucose Monitoring Use: Systematic Review of Trials and Observational Studies. J Diabetes Sci Technol 2020;14:328-37. [PMID: 31452386 DOI: 10.1177/1932296819870849] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
13 Szadkowska A, Michalak A, Łosiewicz A, Kuśmierczyk H, Krawczyk-Rusiecka K, Chrzanowski J, Gawrecki A, Zozulińska-Ziółkiewicz D, Fendler W. Impact of factory-calibrated Freestyle Libre System with new glucose algorithm measurement accuracy and clinical performance in children with type 1 diabetes during summer camp. Pediatr Diabetes 2021;22:261-70. [PMID: 33034075 DOI: 10.1111/pedi.13135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zaharieva DP, Addala A, Simmons KM, Maahs DM. Weight Management in Youth with Type 1 Diabetes and Obesity: Challenges and Possible Solutions. Curr Obes Rep 2020;9:412-23. [PMID: 33108635 DOI: 10.1007/s13679-020-00411-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nagl K, Berger G, Aberer F, Ziko H, Weimann K, Bozic I, Rami-Merhar B, Mader JK. Performance of three different continuous glucose monitoring systems in children with type 1 diabetes during a diabetes summer camp. Pediatr Diabetes 2021;22:271-8. [PMID: 33219728 DOI: 10.1111/pedi.13160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Neu A, Bürger-büsing J, Danne T, Dost A, Holder M, Holl RW, Holterhus P, Kapellen T, Karges B, Kordonouri O, Lange K, Müller S, Raile K, Schweizer R, von Sengbusch S, Stachow R, Wagner V, Wiegand S, Ziegler R. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. Diabetologe 2021;17:557-84. [DOI: 10.1007/s11428-021-00769-1] [Reference Citation Analysis]
17 Palmer BA, Soltys K, Zimmerman MB, Norris AW, Tsalikian E, Tansey MJ, Pinnaro CT. Diabetes Device Downloading: Benefits and Barriers Among Youth With Type 1 Diabetes. J Diabetes Sci Technol 2021;:19322968211059537. [PMID: 34809477 DOI: 10.1177/19322968211059537] [Reference Citation Analysis]
18 Berget C, Messer LH, Forlenza GP. A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy. Diabetes Spectr 2019;32:194-204. [PMID: 31462873 DOI: 10.2337/ds18-0091] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
19 Salah NY, Abido AY, Rashed HR. Relationship of glycaemic derangement using continuous glucose monitoring system with sleep pattern among children with type 1 diabetes. Diabetes Metab Res Rev 2021;37:e3407. [PMID: 32935448 DOI: 10.1002/dmrr.3407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chawla R, Madhu SV, Makkar BM, Ghosh S, Saboo B, Kalra S; On behalf of RSSDI-ESI Consensus Group. RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020. Int J Diabetes Dev Ctries 2020;40:1-122. [DOI: 10.1007/s13410-020-00819-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
21 Lal RA, Basina M, Maahs DM, Hood K, Buckingham B, Wilson DM. One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System. Diabetes Care 2019;42:2190-6. [PMID: 31548247 DOI: 10.2337/dc19-0855] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 23.3] [Reference Citation Analysis]
22 Soni A, Wright N, Agwu J, Timmis A, Drew J, Kershaw M, Moudiotis C, Regan F, Williams E, Wan J, Ng S. A Practical Approach to Continuous Glucose Monitoring (rtCGM) and FreeStyle Libre systems (isCGM) in Children and Young people with Type 1 Diabetes. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109196] [Reference Citation Analysis]
23 Crossen S, Romero C, Reggiardo A, Michel J, Glaser N. Feasibility and Impact of Remote Glucose Monitoring Among Patients With Newly Diagnosed Type 1 Diabetes: Single-Center Pilot Study. JMIR Diabetes 2022;7:e33639. [PMID: 35037887 DOI: 10.2196/33639] [Reference Citation Analysis]
24 Zaharieva DP, Messer LH, Paldus B, O’neal DN, Maahs DM, Riddell MC. Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents with Type 1 Diabetes. Canadian Journal of Diabetes 2020;44:740-9. [DOI: 10.1016/j.jcjd.2020.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Dos Santos TJ, Dave C, MacLeish S, Wood JR. Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey. BMJ Open Diabetes Res Care 2021;9:e002537. [PMID: 34845060 DOI: 10.1136/bmjdrc-2021-002537] [Reference Citation Analysis]
26 Forlenza GP. Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy. Diabetes Technol Ther 2019;21:S24-8. [PMID: 31169433 DOI: 10.1089/dia.2019.0077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
27 Di Molfetta S, Rossi A, Assaloni R, Cherubini V, Consoli A, Di Bartolo P, Guardasole V, Laurenzi A, Lombardo F, Maffeis C, Scaramuzza A, Irace C; Working group of Diabetes, Technology AMD-SID-SIEDP. A guide for the use of LibreView digital diabetes platform in clinical practice: Expert paper of the Italian Working Group for Diabetes and Technology. Diabetes Res Clin Pract 2022;:109867. [PMID: 35405166 DOI: 10.1016/j.diabres.2022.109867] [Reference Citation Analysis]
28 Galderisi A, Sherr JL. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes. Pediatr Ann 2019;48:e311-8. [PMID: 31426099 DOI: 10.3928/19382359-20190725-03] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Perez VA, Husain S, Magro CM, Strom MA, Williams KM, Levin LE. A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes. Pediatr Dermatol 2021;38:239-41. [PMID: 33169884 DOI: 10.1111/pde.14438] [Reference Citation Analysis]
30 Dovc K, Battelino T. Evolution of Diabetes Technology. Endocrinol Metab Clin North Am 2020;49:1-18. [PMID: 31980111 DOI: 10.1016/j.ecl.2019.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
31 Schöttler H, Auzanneau M, Best F, Braune K, Freff M, Heidtmann B, Jung R, Karges B, Klee D, Müller A, Schierloh U, Vogel C, Holl RW. Insulinpumpe, kontinuierliche und kapilläre Glukosemessung bei Kindern, Jugendlichen und Erwachsenen mit Diabetes mellitus: Daten des DPV-Registers zwischen 1995 und 2019. Diabetologie und Stoffwechsel 2020;15:477-86. [DOI: 10.1055/a-1259-1190] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Bozbulut R, Şanlıer N, Döğer E, Bideci A, Çamurdan O, Cinaz P. The effect of beta-glucan supplementation on glycemic control and variability in adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract 2020;169:108464. [PMID: 32971156 DOI: 10.1016/j.diabres.2020.108464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Datye KA, Tilden DR, Parmar AM, Goethals ER, Jaser SS. Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes. Curr Diab Rep 2021;21:22. [PMID: 33991264 DOI: 10.1007/s11892-021-01389-1] [Reference Citation Analysis]
34 Scalzo P. From the Association of Diabetes Care & Education Specialists: The Role of the Diabetes Care and Education Specialist as a Champion of Technology Integration. The Science of Diabetes Self-Management and Care 2021;47:120-3. [DOI: 10.1177/0145721721995478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 De Ridder F, den Brinker M, De Block C. The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education. Ther Adv Endocrinol Metab 2019;10:2042018819865399. [PMID: 31384420 DOI: 10.1177/2042018819865399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
36 Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019;42:1593-603. [PMID: 31177185 DOI: 10.2337/dci19-0028] [Cited by in Crossref: 688] [Cited by in F6Publishing: 519] [Article Influence: 229.3] [Reference Citation Analysis]
37 Gajewska KA, Bennett K, Biesma R, Sreenan S. Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study. BMC Endocr Disord 2020;20:92. [PMID: 32576284 DOI: 10.1186/s12902-020-00573-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Mutlu GY, Eren E, Eviz E, Gokce T, Sakarya S, Hatun S. The attitudes, experiences, and self-competencies of pediatric endocrinology fellows and attending physicians regarding diabetes technology: the Turkey experience. J Pediatr Endocrinol Metab 2022. [PMID: 35334193 DOI: 10.1515/jpem-2022-0024] [Reference Citation Analysis]
39 Dos Santos TJ, Donado Campos JM, Fraga Medin CA, Argente J, Rodríguez-Artalejo F. New insulin delivery devices and glycemic outcomes in young patients with type 1 diabetes: a protocol for a systematic review and meta-analysis. Syst Rev 2019;8:259. [PMID: 31685014 DOI: 10.1186/s13643-019-1171-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 March CA, Nanni M, Kazmerski TM, Siminerio LM, Miller E, Libman IM. Modern diabetes devices in the school setting: Perspectives from school nurses. Pediatr Diabetes 2020;21:832-40. [PMID: 32249474 DOI: 10.1111/pedi.13015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
41 Šumník Z, Pavlíková M, Pomahačová R, Venháčová P, Petruželková L, Škvor J, Neumann D, Vosáhlo J, Konečná P, Čížek J, Strnadel J, Průhová Š, Cinek O; ČENDA Project Group. Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry. Pediatr Diabetes 2021;22:439-47. [PMID: 33533545 DOI: 10.1111/pedi.13184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Nimri R, Nir J, Phillip M. Insulin Pump Therapy. Am J Ther 2020;27:e30-41. [PMID: 31833871 DOI: 10.1097/MJT.0000000000001097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
43 Desrochers HR, Schultz AT, Laffel LM. Use of Diabetes Technology in Children: Role of Structured Education for Young People with Diabetes and Families. Endocrinol Metab Clin North Am 2020;49:19-35. [PMID: 31980118 DOI: 10.1016/j.ecl.2019.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
44 Biester T, Grimsmann JM, Heidtmann B, Rami-Merhar B, Ermer U, Wolf J, Freff M, Karges B, Agena D, Bramlage P, Danne T, Holl RW. Intermittently Scanned Glucose Values for Continuous Monitoring: Cross-Sectional Analysis of Glycemic Control and Hypoglycemia in 1809 Children and Adolescents with Type 1 Diabetes. Diabetes Technol Ther 2021;23:160-7. [PMID: 33084351 DOI: 10.1089/dia.2020.0373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Gajewska KA, Biesma R, Bennett K, Sreenan S. Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study. Acta Diabetol 2021;58:93-105. [PMID: 32862261 DOI: 10.1007/s00592-020-01595-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
46 Predieri B, Leo F, Candia F, Lucaccioni L, Madeo SF, Pugliese M, Vivaccia V, Bruzzi P, Iughetti L. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic. Front Endocrinol (Lausanne) 2020;11:595735. [PMID: 33424771 DOI: 10.3389/fendo.2020.595735] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
47 Gajewska KA, Biesma R, Bennett K, Sreenan S. Availability of and access to continuous subcutaneous insulin infusion therapy for adults with type 1 diabetes in Ireland. Acta Diabetol 2020;57:875-82. [PMID: 32124077 DOI: 10.1007/s00592-020-01497-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
48 Lombardo F, Passanisi S, Tinti D, Messina MF, Salzano G, Rabbone I. High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey. J Diabetes Sci Technol 2020;:1932296820947072. [PMID: 32757778 DOI: 10.1177/1932296820947072] [Reference Citation Analysis]
49 Dovc K, Battelino T. Time in range centered diabetes care. Clin Pediatr Endocrinol 2021;30:1-10. [PMID: 33446946 DOI: 10.1297/cpe.30.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
50 Wright EE, Subramanian S. Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment. Diabetes Technol Ther 2021;23:S12-8. [PMID: 34546082 DOI: 10.1089/dia.2021.0191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ziegler R, Waldenmaier D, Kamecke U, Mende J, Haug C, Freckmann G. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents. Pediatr Diabetes 2020;21:649-56. [DOI: 10.1111/pedi.12993] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
52 Forlenza GP, Kushner T, Messer LH, Wadwa RP, Sankaranarayanan S. Factory-Calibrated Continuous Glucose Monitoring: How and Why It Works, and the Dangers of Reuse Beyond Approved Duration of Wear. Diabetes Technol Ther 2019;21:222-9. [PMID: 30817171 DOI: 10.1089/dia.2018.0401] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
53 Rodríguez-Rodríguez I, Chatzigiannakis I, Rodríguez JV, Maranghi M, Gentili M, Zamora-Izquierdo MÁ. Utility of Big Data in Predicting Short-Term Blood Glucose Levels in Type 1 Diabetes Mellitus Through Machine Learning Techniques. Sensors (Basel) 2019;19:E4482. [PMID: 31623111 DOI: 10.3390/s19204482] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
54 Akil AA, Yassin E, Al-Maraghi A, Aliyev E, Al-Malki K, Fakhro KA. Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era. J Transl Med 2021;19:137. [PMID: 33794915 DOI: 10.1186/s12967-021-02778-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Welsh JB, Derdzinski M, Parker AS, Puhr S, Jimenez A, Walker T. Real-Time Sharing and Following of Continuous Glucose Monitoring Data in Youth. Diabetes Ther 2019;10:751-5. [PMID: 30701468 DOI: 10.1007/s13300-019-0571-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
56 Maahs DM, Lal R, Shalitin S. Diabetes Technology and Therapy in the Pediatric Age Group. Diabetes Technol Ther 2019;21:S123-37. [PMID: 30785328 DOI: 10.1089/dia.2019.2510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
57 Auzanneau M, Karges B, Neu A, Kapellen T, Wudy SA, Grasemann C, Krauch G, Gerstl EM, Däublin G, Holl RW. Use of insulin pump therapy is associated with reduced hospital-days in the long-term: a real-world study of 48,756 pediatric patients with type 1 diabetes. Eur J Pediatr 2021;180:597-606. [PMID: 33258970 DOI: 10.1007/s00431-020-03883-2] [Reference Citation Analysis]
58 Elbarbary N, Moser O, Al Yaarubi S, Alsaffar H, Al Shaikh A, Ajjan RA, Deeb A. Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes. Diab Vasc Dis Res 2021;18:14791641211062155. [PMID: 34898300 DOI: 10.1177/14791641211062155] [Reference Citation Analysis]
59 Cristello Sarteau A, Crandell J, Seid M, Kichler JC, Maahs DM, Wang J, Mayer-Davis E. Characterization of youth goal setting in the self-management of type 1 diabetes and associations with HbA1c: The Flexible Lifestyle Empowering Change trial. Pediatr Diabetes 2020;21:1343-52. [PMID: 32741045 DOI: 10.1111/pedi.13099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Burckhardt MA, Fried L, Bebbington K, Hancock M, Nicholas JA, Roberts A, Abraham MB, Davis EA, Jones TW. Use of remote monitoring with continuous glucose monitoring in young children with Type 1 diabetes: the parents' perspective. Diabet Med 2019;36:1453-9. [PMID: 31257642 DOI: 10.1111/dme.14061] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
61 Addala A, Maahs DM, Scheinker D, Chertow S, Leverenz B, Prahalad P. Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance. Pediatr Diabetes 2020;21:1301-9. [PMID: 32681582 DOI: 10.1111/pedi.13082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
62 Coppin B, Hamood N, Tan F, Scholar M, Goss P. Survey of Australian general paediatricians regarding insulin initiation practices in children with new onset of type 1 diabetes. J Paediatr Child Health 2021. [PMID: 34623008 DOI: 10.1111/jpc.15742] [Reference Citation Analysis]
63 Shah VN, Garg SK. Standardized Hybrid Closed-Loop System Reporting. Diabetes Technol Ther 2021;23:323-31. [PMID: 33252264 DOI: 10.1089/dia.2020.0622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Schütz-Fuhrmann I, Stadler M, Zlamal-Fortunat S, Rami-Merhar B, Fröhlich-Reiterer E, Hofer SE, Mader J, Resl M, Bischof M, Kautzky-Willer A, Weitgasser R. [Insulin pump therapy in children, adolescents and adults, guidelines (Update 2019)]. Wien Klin Wochenschr 2019;131:47-53. [PMID: 30980146 DOI: 10.1007/s00508-019-1485-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Kamrath C, Tittel SR, Kapellen TM, von dem Berge T, Heidtmann B, Nagl K, Menzel U, Pötzsch S, Konrad K, Holl RW. Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry. Lancet Child Adolesc Health 2021;5:17-25. [PMID: 33253630 DOI: 10.1016/S2352-4642(20)30339-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
66 Braune K, Lal RA, Petruželková L, Scheiner G, Winterdijk P, Schmidt S, Raimond L, Hood KK, Riddell MC, Skinner TC, Raile K, Hussain S; OPEN International Healthcare Professional Network and OPEN Legal Advisory Group. Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol 2021:S2213-8587(21)00267-9. [PMID: 34785000 DOI: 10.1016/S2213-8587(21)00267-9] [Reference Citation Analysis]
67 Burckhardt M, Abraham MB, Mountain J, Coenen D, Paniora J, Clapin H, Jones TW, Davis EA. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2019;21:575-80. [DOI: 10.1089/dia.2019.0149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
68 Deeb A, Muammar T, Alsaffar H, Sedaghat S, Al Hassani N, Odeh R, Alkhayyat H, Al Sinani A, Attia N, Adhami S, Elbarbary N. Use of ambulatory glucose monitoring and analysis of ambulatory glucose profile in clinical practice for diabetes management; a position statement of the Arab Society of Paediatric Endocrinology and diabetes. Diabetes Res Clin Pract 2021;173:108671. [PMID: 33493578 DOI: 10.1016/j.diabres.2021.108671] [Reference Citation Analysis]
69 Kahkoska AR, Dabelea D. Diabetes in Youth: A Global Perspective. Endocrinol Metab Clin North Am 2021;50:491-512. [PMID: 34399958 DOI: 10.1016/j.ecl.2021.05.007] [Reference Citation Analysis]
70 Papadakis JL, Anderson LM, Garza K, Feldman MA, Shapiro JB, Evans M, Thompson LG, Weissberg-benchell J. Psychosocial Aspects of Diabetes Technology Use. Endocrinology and Metabolism Clinics of North America 2020;49:127-41. [DOI: 10.1016/j.ecl.2019.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
71 Kim JH. Current status of continuous glucose monitoring among Korean children and adolescents with type 1 diabetes mellitus. Ann Pediatr Endocrinol Metab 2020;25:145-51. [PMID: 32871645 DOI: 10.6065/apem.2040038.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
72 Dos Santos TJ, Donado Campos JM, Argente J, Rodríguez-Artalejo F. Effectiveness and equity of continuous subcutaneous insulin infusions in pediatric type 1 diabetes: A systematic review and meta-analysis of the literature. Diabetes Res Clin Pract 2021;172:108643. [PMID: 33359572 DOI: 10.1016/j.diabres.2020.108643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Martin LD, Hoagland MA, Rhodes ET, Wolfsdorf JI, Hamrick JL, Fehr J, Kim E, Tommerdahl K, Gleich SJ, O’reilly-shah V, Tosone S, Keech K, D’souza G, Honkanen A. Perioperative Management of Pediatric Patients With Type 1 Diabetes Mellitus, Updated Recommendations for Anesthesiologists: . Anesthesia & Analgesia 2020;130:821-7. [DOI: 10.1213/ane.0000000000004491] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
74 Ata A, Er E, Evin F, Işıklar H, Abdullayev N, Demir G, Özen S, Altınok YA, Darcan Ş, Gökşen D. Treatment and long-term follow-up of patients diagnosed with type 1 diabetes mellitus before age 5. J Pediatr Endocrinol Metab 2021;34:201-7. [PMID: 33544547 DOI: 10.1515/jpem-2020-0205] [Reference Citation Analysis]
75 Fredette ME, Zonfrillo MR, Park S, Quintos JB, Gruppuso PA, Topor LS. Self-reported insulin pump prescribing practices in pediatric type 1 diabetes. Pediatr Diabetes 2021;22:758-65. [PMID: 33855806 DOI: 10.1111/pedi.13213] [Reference Citation Analysis]
76 Choe J, Won SH, Choe Y, Park SH, Lee YJ, Lee J, Lee YA, Lim HH, Yoo JH, Lee SY, Kim EY, Shin CH, Kim JH. Temporal Trends for Diabetes Management and Glycemic Control Between 2010 and 2019 in Korean Children and Adolescents with Type 1 Diabetes. Diabetes Technol Ther 2021. [PMID: 34704794 DOI: 10.1089/dia.2021.0274] [Reference Citation Analysis]
77 Lee MY, Tanenbaum ML, Maahs DM, Prahalad P, Moore WV. Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action. Case Reports in Endocrinology 2022;2022:1-5. [DOI: 10.1155/2022/9911736] [Reference Citation Analysis]
78 Dos Santos TJ, Rodrigues TC, Puñales M, Arrais RF, Kopacek C. Newest Diabetes-Related Technologies for Pediatric Type 1 Diabetes and Its Impact on Routine Care: a Narrative Synthesis of the Literature. Curr Pediatr Rep 2021;:1-12. [PMID: 34430071 DOI: 10.1007/s40124-021-00248-7] [Reference Citation Analysis]
79 Gurnurkar S, Owens L, Chalise S, Vyas N. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2021;34:311-7. [PMID: 33618445 DOI: 10.1515/jpem-2020-0587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Hackl L, Bonfig W, Bechtold-Dalla Pozza S, Lanzinger S, Treptau N, Raile K, Elpel U, Ludwig KH, Buchal G, Holl RW; DPV registry. Size matters: Influence of center size on quality of diabetes control in children and adolescents with type 1 diabetes-A longitudinal analysis of the DPV cohort. Pediatr Diabetes 2021. [PMID: 34779099 DOI: 10.1111/pedi.13283] [Reference Citation Analysis]
81 Lin R, Brown F, James S, Jones J, Ekinci E. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus. Diabet Med 2021;38:e14528. [PMID: 33496979 DOI: 10.1111/dme.14528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
82 Fleming GA, Petrie JR, Bergenstal RM, Holl RW, Peters AL, Heinemann L. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia 2020;63:229-41. [PMID: 31802144 DOI: 10.1007/s00125-019-05034-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 22.0] [Reference Citation Analysis]
83 Dovc K, Battelino T. New technical approach to the diabetes therapy. Minerva Pediatr 2020;72:263-77. [PMID: 32418412 DOI: 10.23736/S0026-4946.20.05865-X] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Urakami T, Yoshida K, Kuwabara R, Mine Y, Aoki M, Suzuki J, Morioka I. Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes. J Diabetes Investig 2021. [PMID: 34143544 DOI: 10.1111/jdi.13618] [Reference Citation Analysis]
85 Sumnik Z, Szypowska A, Iotova V, Bratina N, Cherubini V, Forsander G, Jali S, Raposo JF, Stipančic G, Vazeou A, Veeze H, Lange K; SWEET study group. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective. Pediatr Diabetes 2019;20:434-43. [PMID: 30773756 DOI: 10.1111/pedi.12833] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
86 Delagrange M, Dalla-Vale F, Salet R, Asensio-Weiss V, Moulin P, Cabaret B, Colmel C, Morin C, Talvard M, LeTallec C. Impact of deprivation on glycaemic control in youth with type 1 diabetes in the southwestern region of France. Pediatr Diabetes 2021;22:796-806. [PMID: 33205845 DOI: 10.1111/pedi.13156] [Reference Citation Analysis]
87 Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019;42:1593-603. [PMID: 31177185 DOI: 10.2337/dci19-0028] [Cited by in Crossref: 914] [Cited by in F6Publishing: 1] [Article Influence: 304.7] [Reference Citation Analysis]
88 Codner E, Acerini CL, Craig ME, Hofer SE, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018: What is new in diabetes care? Pediatr Diabetes 2018;19:5-6. [DOI: 10.1111/pedi.12759] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
89 Predieri B, Bruzzi P, Bigi E, Boncompagni A, Bocchi F, Cenciarelli V, Madeo SF, Poluzzi S, Pugliese M, Toffoli C, Lucaccioni L, Iughetti L. Health-related quality of life and metabolic control in immigrant and Italian children and adolescents with type 1 diabetes and in their parents. Pediatr Diabetes 2020;21:1031-42. [PMID: 32418308 DOI: 10.1111/pedi.13042] [Reference Citation Analysis]
90 Kahkoska AR, Crandell J, Driscoll KA, Kichler JC, Seid M, Mayer-Davis EJ, Maahs DM. Dysglycemia among youth with type 1 diabetes and suboptimal glycemic control in the Flexible Lifestyle Empowering Change trial. Pediatr Diabetes 2019;20:180-8. [PMID: 30536572 DOI: 10.1111/pedi.12805] [Reference Citation Analysis]